NeueHealth, Inc. (NEUE)
(Delayed Data from NYSE)
$6.72 USD
-0.01 (-0.15%)
Updated Aug 8, 2025 03:49 PM ET
4-Sell of 5 4
D Value A Growth B Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NEUE 6.72 -0.01(-0.15%)
Will NEUE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NEUE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NEUE
ModivCare (MODV) Q4 Earnings and Revenues Top Estimates
Doximity (DOCS) Q3 Earnings and Revenues Top Estimates
NEUE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Charles River Laboratories (CRL) Q3 Earnings and Revenues Beat Estimates
Biodesix, Inc. (BDSX) Reports Q3 Loss, Misses Revenue Estimates
NeueHealth (NEUE) Upgraded to Buy: What Does It Mean for the Stock?
Other News for NEUE
NeueHealth signals ongoing growth with 45% increase in consumers served while expanding NeuePulse platform
NeueHealth, Inc. (NEUE) Q2 2025 Earnings Call Transcript
NeueHealth Inc (NEUE) Q2 2025 Earnings Call Highlights: Sustained Profitability and Strategic ...
Q2 2025 NeueHealth Inc Earnings Call Transcript
NeueHealth GAAP EPS of -$2.62, revenue of $209.1M